Home > Healthcare > Medical Devices > Therapeutic Devices > Topical Wound Agents Market

Topical Wound Agents Market Size

  • Report ID: GMI7712
  • Published Date: Dec 2023
  • Report Format: PDF

Topical Wound Agents Market Size

Topical Wound Agents Market size was valued at USD 1.7 billion in 2023 and is anticipated to grow at a CAGR of over 7.7% between 2024 and 2032. Topical wound agents refer to the management and treatment of wounds using products that are applied directly to the skin surface. The rising prevalence of both chronic and acute wounds functions as a driving factor for the industry gains. For instance, in the U.S., it is estimated that approximately 6 million people suffer from chronic wounds, annually. These wounds includes diabetic foot ulcers and pressure ulcers, venous ulcers, arterial ulcers, among others.

 

Moreover, the demand for topical wound agents is fueled by factors such as the growing geriatric population base prone to chronic conditions and impaired wound healing. Additionally, increased surgical procedures, surge in awareness regarding appropriate wound care practices, along with the availability of cutting-edge treatments.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for topical wound agents was valued at USD 1.7 billion in 2023 and is estimated to reach USD 3.4 billion by 2032, owing to the rising prevalence of both chronic and acute wounds.

The chronic wound segment accounted for 79% market share in 2023, driven by the need to address specific challenges associated with diabetic ulcers, reduce complications, and promote effective wound healing in individuals with diabetes.

U.S. market accounted for USD 710 million revenue size in 2023, backed by aging population in the region, having slow wound healing and skin issues, creating a higher demand for wound care solutions.

Smith & Nephew plc., Teva Pharmaceutical Industries Ltd., Mölnlycke Health Care AB, 3M Company, Medline Industries, Inc., Arch Therapeutics, Inc. Mylan N.V., AstraZeneca and Osiris Therapeutics, Inc.

Topical Wound Agents Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 449
  • Countries covered: 18
  • Pages: 196
 Download Free Sample